First, CA125 and CEA are commonly used for gynaecological diseases and colorectal diseases, and pancreatic IPMN has its own specific metabolic features, i.e. abundant mucin production, so the original commonly used cut-off values are not suitable. This evidence concerns the gene MUC5AC and pancreatic intraductal papillary-mucinous neoplasm.